Ticker: ZTS

Company Overview: Zoetis Inc. (NYSE: ZTS) is a leading global player in the animal health industry, focusing on the development, manufacturing, and marketing of medicines, vaccines, diagnostic products, and related services. With a strong portfolio across various species and substantial investmen...

Zoetis (NYSE: ZTS) faces a downgrade due to slowing growth and heightened competition in the animal health market. Traders should reevaluate strategies, monitor earnings, and stay informed to navigate potential market share erosion and squeezed margins.

Company Overview: Zoetis Inc. (NYSE: ZTS) is a global leader in the animal health industry, focused on developing medicines, vaccines, and diagnostic products for animals. Latest Income Statement Highlights (Q1 2025): Revenue: $2,220 million (up 1% from $2,190 million in Q1 2024) Gross Profit: $...

Zoetis reports strong Q1 with earnings of $1.38 per share, driven by high demand for pet medicines and vaccines.